Delivery Order SPE2DB22D3301-SPE2DB25FY7FU
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 5 gram/50 ml vials, a pharmaceutical product. The contract has a ceiling value of $3,036.70 and a period of performance ending on July 30, 2025. The contract is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 5 gram/50 ml vials, a pharmaceutical product, with a ceiling value of $1,518.35. The contract is a firm fixed-price delivery order and is not set aside for any socioeconomic program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 ml vials. The contract has a ceiling value of $6,073.40 and a period of performance through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 20 gram/200 ml vials, a specialized pharmaceutical product. The contract has a ceiling value of $14,161.68 and a completion date of July 24, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product GAMUNEX-C, a 20 gram/200 ml vial. The contract is a firm fixed-price delivery order with a ceiling value of $7,080.84 and a period of performance extending through July 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 mL vials. The contract has a ceiling value of $3,036.70 and a period of performance through July 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GAMUNEX-C 5 GRAM/50 ML VIAL 50ML, a pharmaceutical product, and has a ceiling value of $1,822.02. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 gram/400 ml vials, a pharmaceutical product, with a ceiling value of $6,981.60 and a performance period ending on July 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GAMUNEX-C 40 gram/400 ml vials, a medical product used for various healthcare purposes. The contract has a firm fixed price and a ceiling value of $13,963.20, with a period of performance through April 28, 2025. This award is not set-aside and represents an open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,180.14, is for the supply of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period that extends through May 23, 2025. This contract is not designated as a set-aside and was awarded through open...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY7FUDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 5 gram/50 ml vial, a pharmaceutical product, with a ceiling value of $3,036.70 and a period of performance through July 24, 2025. The contract is a firm-fixed price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs and other government agencies through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/2/25 |